NX EQ Laparoscopic Insufflators (VA-26-00024810)

Strategic Acquisition Center Fredericksburg (36C10G) · United States government procurement

Closed May 07, 2026. GlobalGov surfaces government procurement from around the world, including the markets your competitors overlook.

Closed
Status

Opportunity Overview

This is a combined synopsis/solicitation for commercial products prepared in accordance with FAR part 12. This announcement constitutes the only solicitation. Offers are being requested and a separate written solicitation will not be issued.
Solicitation number 36C10X26R0009 is issued as a Request for Proposal (RFP) for Laparoscopic Insufflators.
This acquisition is set-aside for Service-Disabled Veteran-Owned Small Business (SDVOSB) concerns. This solicitation incorporates provisions and clauses by reference. The full text of provisions and clauses may be accessed electronically at www.acquisition.gov.
Line Items: Refer to ATTACHMENT D PRICE COST SCHEDULE NX EQ NX EQ Laparoscopic Insufflators for CLINs, quantities, and units of measure.
Description of Requirements: Offerors shall provide NX EQ Laparoscopic Insufflators that meet the salient characteristics listed in ATTACHMENT B PRODUCT DESCRIPTION. Only new OEM equipment is acceptable. No refurbished, remanufactured, or gray market items will be considered.
Delivery and Acceptance: Delivery is FOB Destination. Specific delivery locations and dates will be identified in individual orders issued under the contract.

Your competitors are watching the same crowded contracts everyone else is. Track live opportunities like this one worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.

Start Free

Solicitation Details

Issuing agencyStrategic Acquisition Center Fredericksburg (36C10G)
CountryUnited States
CategoryPharmaceuticals
NAICS339113
PSC6515
PublishedApril 23, 2026
Procurement stageActive solicitation
ClosedMay 07, 2026
StatusClosed — no longer accepting responses
Official sourceView original notice
Last verifiedOctober 11, 2026

Source: U.S. Government (SAM.gov) — public domain. GlobalGov is not affiliated with or endorsed by the United States Government.

Browse Similar Open Opportunities in United States

PPVG GEN V Award
National Retardant
PPVG GEN V AWARD SPE2DX25D8000
Febuxostat National Contract
Ziprasidone Capsules
Hydrocodone Acetaminophen
Olanzapine SPE2D2-25-D-0011 Award
Olopatadine HCL 0.1% Ophthalmic Solution

See every United States Pharmaceuticals opportunity your competition is missing. Free for 14 days.

Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.

Start Free Trial — No Card Required

Free 14-day trial · no card required

See who is already competing here →

Get a free United States Pharmaceuticals intelligence report in your inbox

A personalized report on United States Pharmaceuticals opportunities, emailed in 5-10 minutes. One per month, no account needed.